VeriMomginkgo biloba leaf powder은 임신 중 안전한가요?
No harmonised CLP reproductive classification for Ginkgo biloba leaf (ECHA Annex VI). No SCCS or CIR safety assessment identifying reproductive hazards for topical use; available animal reproductive signals are from high‑dose oral exposures to extracts (PubMed) and do not establish a topical reproductive hazard. Dermal absorption from a cosmetic powder formulation is expected to be negligible, so systemic exposure in pregnancy from topical use is minimal (ECHA registration dossiers/PubChem for composition; PubMed for oral studies).
성분
ginkgo biloba leaf powder
알려진 위험 없음100
/100
0
Pregnancy-safe products containing ginkgo biloba leaf powder
Related ingredients
Frequently asked questions
- ginkgo biloba leaf powder은 임신 중 안전한가요?
- No harmonised CLP reproductive classification for Ginkgo biloba leaf (ECHA Annex VI). No SCCS or CIR safety assessment identifying reproductive hazards for topical use; available animal reproductive signals are from high‑dose oral exposures to extracts (PubMed) and do not establish a topical reproductive hazard. Dermal absorption from a cosmetic powder formulation is expected to be negligible, so systemic exposure in pregnancy from topical use is minimal (ECHA registration dossiers/PubChem for composition; PubMed for oral studies).
- ginkgo biloba leaf powder은 모유 수유 중 안전한가요?
- No harmonised classification or authoritative cosmetic‑safety body (CIR/SCCS) conclusion indicating risk to lactation or breastfed infants from topical use. Systemic transfer via breastmilk is unlikely from low dermal exposure to a topical powder; oral high‑dose animal data do not translate to typical cosmetic use (PubMed, ECHA/CosIng).
- ginkgo biloba leaf powder은 아기 피부에 안전한가요?
- Hazard and mechanism: no authoritative evidence of reproductive/developmental toxicity relevant to infant topical exposure (h=0, m=0). Exposure: increased by +1 for baby skin (e=1) because infants have an immature barrier and higher surface‑area‑to‑weight—if the ingredient has any measurable dermal absorption, infant exposure is higher than adult. There are no infant‑specific safety studies for topical Ginkgo biloba leaf powder in cosmetic products to demonstrate otherwise (PubMed/CosIng/ECHA).
- VeriMom은 ginkgo biloba leaf powder을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 ginkgo biloba leaf powder을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 ginkgo biloba leaf powder 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.